This report was our free report of the day on a previous date — it has since expired.
Today's free report is available: ACMR 10-Q — ACM Research revenue jumps 36.6% to $367.7M, but net income falls 95.7% …
Get notified when INSP files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- New Qui Tam Lawsuit (new) — A former employee has filed a qui tam lawsuit under the False Claims Act, alleging improper certification of physician eligibility for Medicare reimbursement. The government declined to intervene, but the relator is proceeding with the litigation.
Revenue fell 7.6% to $200.6M in the second quarter, which the company attributes to adverse impacts of coding and reimbursement challenges, while net earnings turned positive at $314,000.
Filed August 3, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 4, 2025 · ~1 min read
Key Changes
-
high
Revenue declined 7.6% to $200.6M, driven by a 9.6% drop in U.S. revenue to $187.3M, which the company attributes to adverse impacts of coding and reimbursement challenges.
-
medium
International revenue grew 33.6% to $13.3M.
-
medium
Gross margin improved to 85.5% from 84.0%, which the company attributes to increased sales mix of the Inspire V system, which has a higher gross margin than the Inspire IV system.
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Partner
Trade INSP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 4, 2026 · How we verify